Cargando…

Precision-Enhancing Risk Stratification Tools for Selecting Optimal Treatment Durations in Tuberculosis Clinical Trials

Rationale: No evidence-based tools exist to enhance precision in the selection of patient-specific optimal treatment durations to study in tuberculosis clinical trials. Objectives: To develop risk stratification tools that assign patients with tuberculosis into risk groups of unfavorable outcome and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Imperial, Marjorie Z., Phillips, Patrick P. J., Nahid, Payam, Savic, Radojka M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663006/ https://www.ncbi.nlm.nih.gov/pubmed/34346856 http://dx.doi.org/10.1164/rccm.202101-0117OC

Ejemplares similares

Pharmacokinetic analysis across studies to drive knowledge‐integration: A tutorial on individual patient data meta‐analysis (IPDMA)
por: van Wijk, Rob C., et al.
Publicado: (2023)

A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis
por: Imperial, Marjorie Z., et al.
Publicado: (2018)

Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis
por: Imperial, Marjorie Z., et al.
Publicado: (2018)

A comparison of clinical development pathways to advance tuberculosis regimen development
por: Chang, V., et al.
Publicado: (2022)

Proposed Linezolid Dosing Strategies to Minimize Adverse Events for Treatment of Extensively Drug-Resistant Tuberculosis
por: Imperial, Marjorie Z, et al.
Publicado: (2021)

Mathematical model and tool to explore shorter multi-drug therapy options for active pulmonary tuberculosis
por: Fors, John, et al.
Publicado: (2020)

Effectiveness and Pharmacokinetic Exposures of First-Line Drugs Used to Treat Drug-Susceptible Tuberculosis in Children: A Systematic Review and Meta-Analysis
por: Solans, Belén P, et al.
Publicado: (2023)

Tuberculosis drugs’ distribution and emergence of resistance in patient’s lung lesions: A mechanistic model and tool for regimen and dose optimization
por: Strydom, Natasha, et al.
Publicado: (2019)

Analysis of Dynamic Efficacy Endpoints of the Nix-TB Trial
por: Solans, Belén P, et al.
Publicado: (2023)

The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials
por: Vernon, Andrew, et al.
Publicado: (2019)

Individualized Treatment Duration in Tuberculosis Treatment: Precision versus Simplicity
por: Adjobimey, Menonli, et al.
Publicado: (2021)

Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology
por: Dooley, Kelly E., et al.
Publicado: (2019)

MediBoost: a Patient Stratification Tool for Interpretable Decision Making in the Era of Precision Medicine
por: Valdes, Gilmer, et al.
Publicado: (2016)

Clinicians’ Perceptions towards Precision Medicine Tools for Cardiovascular Disease Risk Stratification in South Africa
por: Kamp, Michelle, et al.
Publicado: (2022)

Model-Based Efficacy and Toxicity Comparisons of Moxifloxacin for Multidrug-Resistant Tuberculosis
por: Yun, Hwi-Yeol, et al.
Publicado: (2021)

Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape
por: Phillips, Patrick P. J., et al.
Publicado: (2019)

Promise and Peril of Pretomanid–Rifamycin Regimens for Drug-susceptible Tuberculosis
por: Velásquez, Gustavo E., et al.
Publicado: (2023)

Randomized clinical trials to identify optimal antibiotic treatment duration
por: Horsburgh, C Robert, et al.
Publicado: (2013)

Artificial intelligence for precision oncology: beyond patient stratification
por: Azuaje, Francisco
Publicado: (2019)

Toward Molecular Stratification and Precision Medicine in Systemic Sclerosis
por: Noviani, Maria, et al.
Publicado: (2022)

Second generation multiple reaction monitoring assays for enhanced detection of ultra-low abundance Mycobacterium tuberculosis peptides in human serum
por: Mehaffy, Carolina, et al.
Publicado: (2017)

Enhancing risk stratification for life‐threatening ventricular arrhythmias in dilated cardiomyopathy: the peril and promise of precision medicine
por: Asatryan, Babken, et al.
Publicado: (2020)

A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP)
por: Phillips, Patrick P. J., et al.
Publicado: (2016)

A systematic review of endpoint definitions in late phase pulmonary tuberculosis therapeutic trials
por: Hills, N. K., et al.
Publicado: (2021)

Precision medicine in the treatment stratification of AML patients: challenges and progress
por: Lohse, Ines, et al.
Publicado: (2018)

Optimizing Hydroxychloroquine Dosing for Patients With COVID‐19: An Integrative Modeling Approach for Effective Drug Repurposing
por: Garcia‐Cremades, Maria, et al.
Publicado: (2020)

Special Issue on Precision Risk Stratification-Based Screening in Colorectal Cancer
por: Stojadinovic, Alexander, et al.
Publicado: (2013)

Junctional Epidermolysis Bullosa: Allelic Heterogeneity and Mutation Stratification for Precision Medicine
por: Condrat, Irina, et al.
Publicado: (2019)

Integrating cell cycle score for precise risk stratification in ovarian cancer
por: Chen, Lingying, et al.
Publicado: (2022)

Risk stratification tools in emergency general surgery
por: Havens, Joaquim Michael, et al.
Publicado: (2018)

Risk stratification tools in primary care in Europe
por: De Manuel-Keenoy, E
Publicado: (2023)

Computer-interpretable guidelines: electronic tools to enhance the utility of thyroid nodule clinical practice guidelines and risk stratification tools
por: Garber, Jeffrey R., et al.
Publicado: (2023)

Risk stratification for malignant progression in Barrett’s esophagus: Gender, age, duration and year of surveillance
por: Gatenby, Piers, et al.
Publicado: (2016)

Longitudinal Model-Based Biomarker Analysis of Exposure-Response Relationships in Adults with Pulmonary Tuberculosis
por: Gewitz, Andrew D., et al.
Publicado: (2021)

A Pilot Study of Short-Duration Sputum Pretreatment Procedures for Optimizing Smear Microscopy for Tuberculosis
por: Daley, Peter, et al.
Publicado: (2009)

Clinical Pharmacokinetics of Oral Sodium Selenite and Dosing Implications in the Treatment of Patients with Metastatic Cancer
por: Jayachandran, Priya, et al.
Publicado: (2021)

Artificial Intelligence to Decode Cancer Mechanism: Beyond Patient Stratification for Precision Oncology
por: Patel, Sandip Kumar, et al.
Publicado: (2020)

Early Diagnosis, Early Stratification, and Early Intervention to Deliver Precision Medicine in IBD
por: Noor, Nurulamin M, et al.
Publicado: (2021)

Molecular classifications of prostate cancer: basis for individualized risk stratification and precision therapy
por: Ge, Qintao, et al.
Publicado: (2023)

Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure–response relations from two phase II clinical trials
por: Savic, RM, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_j7fd2cdrjqjcs7eejlbcosq381